CORT

#3684
Corcept Therapeutics Incorporated - Common Stock
0.6 9 USD
-98.98%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
0.69
0.69
Jahresspanne
0.69
89.00
Tagesänderung
-98.98%
Monatliche Änderung
-98.52%
6 month change
-99.11%
Jahresänderung
-99.05%
Vorheriger Schlusskurs
68.3 8
Open
0.6 9
Tief
0.6 9
High
0.6 9
Volumen
220
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert 202020212022202320242025 TTM

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Nachrichten